Načítá se...
The Impact of IDH1 Mutation and MGMT Promoter Methylation on Recurrence-Free Interval in Glioblastoma Patients Treated With Radiotherapy and Chemotherapeutic Agents
The aim of this study is to investigate the relationship between isocitrate dehydrogenase-1 (IDH1) mutation and O(6)-methylguanine-DNA methyltransferase (MGMT) promoter methylation with recurrence-free interval in glioblastoma patients treated with chemoradiotherapies. Clinical data were collected f...
Uloženo v:
| Vydáno v: | Pathol Oncol Res |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Frontiers Media S.A.
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8262235/ https://ncbi.nlm.nih.gov/pubmed/34257620 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/pore.2021.1609778 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|